A two-dose Pfizer/BioNTech vaccination appeared to provide just 33% protection against infection during South Africa's current omicron wave, but 70% protection against hospitalization.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}